Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: The potential value of the PEPs study

Literals

• ou:eid
  • 2-s2.0-84869995013
• dcterms:title
  • Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: The potential value of the PEPs study
• bibo:doi
  • 10.2217/pgs.12.159
• ou:tipoPublicacion
  • Review
• dcterms:contributor
  • Mas S.; Llerena A.; Saiz J.; Bernardo M.; Lafuente A.
• dcterms:publisher
  • Pharmacogenomics
• bibo:page_range
  • 1773-1782
• bibo:eissn
  • 1744-8042
• dcterms:creator
  • Mas S.
• fabio:hasPublicationYear
  • 2012
• vivo:identifier
  • 2012-813
• bibo:issn
  • 1462-2416
• vcard:url
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84869995013&origin=inward
• ou:urlOrcid
  • http://europepmc.org/abstract/med/23171340
• ou:urlScopus
  • https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84869995013&origin=inward
• ou:vecesCitado
  • 16
• bibo:volume
  • 13

Typed Literals

• dcterms:created
  • 2012-11-01T00:00:00 (xsd:dateTime)

Relations

• ou:publicadaEnRevista
  • PHARMACOGENOMICS

Inverse Relations

• Has related: ou:tienePublicacion
  • ADRIÁN LLERENA RUIZ